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Objective. To evaluate the peri-operative results of Anaconda endograft in the first 49 cases treated in a single centre.
Methods. The study was carried out prospectively on cases of infrarenal abdominal aortic aneurysm (AAA) treated with
Anaconda endograft. The characteristics of the proximal aortic neck and of the iliac access vessels were considered. The
following operative results were assessed: the main body oversizing, the need to correct the positioning of the main body,
the use of iliac extensions, the use of ballooning, the covering of patent hypogastric arteries, the presence of endoleaks and
the need for conversion. Peri-operative (30 days) mortality and morbidity were also considered.
Results. Of the 49 cases treated, 44 were males with a mean age of 73 years (range: 55e89 yrs; SD 7 yrs). The mean
diameter of the AAA was 56 mm (range 45e91 mm; SD 11); 4 cases had common iliac aneurysms with a diameter
>3 cm. The mean neck diameter and length were 23 mm (range 19e28 mm; SD 3) and 25 mm (range 15e50 mm;
SD 10) respectively. An aortic neck angle between 40 and 70 was present in 10 cases (20%) (mean 58;
SD 15), and 20 cases (41%) had iliac tortuosity with an angle greater than 60 (mean 85; SD 25). There were
no cases of conversion or intra-operative death. One (2%) peri-operative death occurred, for reasons not related to the
endograft. There were two cases of iliac limb thrombosis. CT at one month showed 12 cases (25%) of type II endoleak.
There were no cases of type I or type III endoleaks.
Conclusions. The preliminary data of this series demonstrates that the Anaconda endograft has good peri-operative
results in the treatment of infrarenal AAAs with a neck length not less than 15 mm.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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The surgical treatment of abdominal aortic aneurysms
(AAA) was for many years the therapeutic option of
choice.1 In the early 1990s Parodi et al.2 introduced en-
dovascular abdominal aortic aneurysm repair (EVAR)
with the aim of reducing mortality and morbidity
thanks to a minimally invasive approach. The evolu-
tion of the materials used in EVAR is justified by the
need to have more reliable endografts both in the im-
mediate and the long term. Despite the notable prog-
ress in technology, the ‘‘ideal’’ endograft has not yet
been designed and limitations in the method still ex-
ist. Two randomized multicenter trials (EVAR-13 and
DREAM4,5) comparing the results of EVAR and those
of conventional surgical treatment, carried out at the
end of the 90s concluded that despite being equivalent
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is a significant increase in complications and re-do op-
erations in the EVAR group. This encouraged the con-
tinuing search for new models of endografts that can
reduce these problems, in particular those connected
with proximal sealing and obstruction of the iliac
limb. The aim of this study was to examine the intra-
operative and peri-operative results (at 30 days) ob-
tained by using the new Anaconda endograft
(Vascutek, Terumo, Inchinnan, Scotland) in the treat-
ment of infrarenal abdominal aortic aneurysm
(AAA). The study was conducted without funding
by the Company producing the device.
Materials and Methods
Stent grafts
The Anaconda endograft is a trimodular stent graft,
the result of an initial prototype created andn behalf of European Society for Vascular Surgery.
694 A. Freyrie et al.implanted by Lauterjung in 1996. The endograft
consists of a woven dacron prosthesis supported by
self-expanding nitinol ring-stents (Fig. 1). The proxi-
mal part of the main body consists of two nitinol rings
at a variable distance from each other according to the
diameter, with a saddle shape which is not intended
for suprarenal or juxtrarenal positioning. The main
body is unsupported by other stents or longitudinal
bars. A passive proximal sealing is supported by the
radial force of the two nitinol stents. There is also an
active fixation system consisting of four pairs of
hooks, two on the lateral margins and two on the front
and rear margins. The proximal stent is connected to
the release system by a series of wires that allow the
device to be collapsed and repositioned. Eight differ-
ent diameters of the main body are available, ranging
from 19.5 to 34 mm. The iliac legs consist of a woven
Dacron prosthesis and a series of nitinol ring-stents,
these too being at a variable distance according to
diameter. The diameters available range from 9 to
18 mm and for each diameter four configurations are
available, measuring 60, 100, 120 and 140 mm in
length. Flared legs to allow treatment of iliac arteries
up to 21 mm in diameter recently became available.
Thedevice is alsofittedwith aguidewirewith amag-
net inside the contralateral gate, allowing easy cannula-
tion by coupling with an external guidewire with
anothermagnet inserted from the opposite side (Fig. 2).
Patient selection
The Anaconda endograft can be used in infrarenal
AAAs with an aortic neck greater than or equal toEur J Vasc Endovasc Surg Vol 34, December 200715 mm in length and a diameter of between 16 and
31.5 mm, and with a distal landing zone more than
15 mm long with a diameter of between 7 and 17 mm.
Patients with acute AAA rupture were excluded
from the study. All cases of asymptomatic AAAs
with a minimum CT diameter greater than 50 mm,
symptomatic AAAs (with contained rupture) and
cases of infrarenal aortic dilatation associated with il-
iac aneurysms with a diameter greater than 30 mm
were enrolled in the study. As regards the proximal
neck, we also excluded cases with circumferential cal-
cification or thrombus and with an angle greater than
90. Exclusion criteria also included the presence of
access arteries inadequate for the insertion of the de-
livery system which is 20-22 F for the ipsilateral side
and 18 F for the contralateral side. The presence of tor-
tuous iliac access was not considered an exclusion cri-
terion. Due to the study type and the endograft
characteristics (marketed under CE licence), the Ethi-
cal Committee of our Hospital did not find it neces-
sary to approve the project. All patients gave their
written consent.
Planning of the implant
All cases were studied pre-operatively with multi-
slice 16 layer CTA (G.E. Light Speed) with 5 mm
slices, with baseline scanning (Iomeron 400, Bracco,
Milan, Italy). In selected cases (short neck) 1 mm slices
were obtained. Images were taken from 2 cm above
the celiac axis to the femoral artery bifurcation. The
characteristics of the proximal aortic neck (diameter,
length, angle, presence of calcification or thrombus)Fig. 1. Artist’s interpretation (a) and post-op Angio-CT control (b) of Anaconda endograft.
695Preliminary Results of Anacondaand of the iliac arteries (diameter, tortuosity, presence
of calcification or wall thrombus) were considered to-
gether with the presence of polar renal arteries and of
a patent inferior mesenteric artery. The data were
entered in a special work-sheet and then transferred
to the database.
Implant technique
In all cases, the procedure was performed in the oper-
ating room using a GE OEC 9800 plus imaging system
(GE OEC Medical Systems, Inc., Salt Lake City, Utah,
USA). The Anaconda endograft was implanted using
bilateral inguinal surgical access, positioning a 0.035
guide wire (Radiofocus Guide Wire M, Terumo Cor-
poration, Tokio, Japan) for the insertion of the 9F
sheath (Togo Medikit Corporation, Tokio, Japan) in
both common femoral arteries. A 5F pig-tail catheter
(Cordis Corporation, Miami, FL USA) used for pre-
operative angiogram was positioned from the groin
opposite the side chosen for the insertion of the
main body and left in the infrarenal site to check the
final positioning of the main body. The ipsilateral
ultra-stiff 0.035 guide (Vascutek, Terumo, Inchinnan,
Scotland) was then inserted for placement of the
delivery system of the main body which must be
inserted until the tip of the proximal stent is aligned
with the lower margin of the lowest renal artery.
The main body was unsheathed and a control angio-
gram was performed. If the position of the device
Fig. 2. Magnet system for facilitated cannulation of the
contralateral gate in the artist’s interpretation (a) and intra-
operative X-ray (circle) (b).was considered unsatisfactory, the device was col-
lapsed and repositioned by moving it in a cranio-
caudal direction, rotating it and tilting it on its
longitudinal axis by pulling back and turning the con-
trol collar on the delivery system handle.
When this first stage is complete, the contralateral
iliac leg is introduced. The contralateral 0.035 guide-
wire with a magnet at the tip (Vascutek, Terumo, In-
chinnan, Scotland) is inserted and moved towards
the internal magnet until the magnets are coupled to-
gether. The two guides are moved forward together
until they are above the renal arteries and then un-
coupled. The contralateral guide is used to position
the delivery system of the iliac leg which is released
after checking the correct positioning of its distal
marker. The device is then completely released, the
delivery system is withdrawn through the sheath
and removed. If necessary, one or more extensions
can then be positioned with the same approach. The
extension must be released so that its proximal
marker is approximately five rings upstream of the
distal marker of the iliac leg. Finally, the ipsilateral il-
iac leg and any extensions are positioned in the same
way as described for the contralateral iliac leg.
An angiogram is performed at the end of the proce-
dure and, if necessary, ballooning of the proximal
neck, the docking zone and the iliac legs to ensure
adequate sealing and to correct any stenoses.
Peri-operative imaging
Within one month of the procedure all patients under-
went abdominal X-ray in two projections, echo-color
Doppler scan, ultrasound with contrast medium
(Sono Vue, Bracco) and CTA. The ultrasound scans
were carried out with an HDI 5000 scanner (Philips,
Bothell, Washington, US) equipped with contrast-
specific software, by means of transverse and longi-
tudinal scans of the abdominal aorta and the iliac
arteries. Echo-Color-Doppler was used to measure
the maximum antero-posterior and latero-lateral dia-
meter of the aneurysm sac and the diameter of the in-
frarenal neck. Color Doppler was also used to reveal
any stenoses at the level of the iliacs or the presence
of endoleaks. Ultrasound scans with contrast medium
were performed by i.v. bolus injection of 5 ml of sec-
ond generation SonoVue contrast medium (Bracco,
Milan, Italy).
Variations in diameter of the proximal neck and the
maximum diameter of the aneurysm were taken into
consideration, as were complications correlated to
the implant, such as the presence of endoleaks and
branch thromboses.Eur J Vasc Endovasc Surg Vol 34, December 2007
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Patients and procedures
Between September 2005 and September 2006, 115
patients with AAA were treated: 43 with open repair
and 72 by means of EVAR (63%).
This study was carried out prospectively on the
first 49 cases of infrarenal AAA consecutively treated
with the Anaconda endograft. Of the 49 patients (44
males and 5 females), 45 had infrarenal AAAs and 4
had iliac aneurysms associated with aortic dilatation.
The mean age of the patients was 73 years (range: 55e
89 years; SD 7 years) with a pre-operative ASA III/
IV risk in 92% of the cases. The risk factors are re-
ported in Table 1. Among the patients with infrarenal
AAA, the mean diameter of the aneurysm was 56 mm
(range 45e91 mm; SD 11), with two cases of con-
tained rupture and one case of inflammatory aneurysm.
In all 4 cases of aneurysms of the common iliac
arteries, the diameter was greater than 30 mm.
As far as the morphological characteristics of the
neck are concerned, the mean diameter was 23 mm
(range 19e28 mm; SD 3) and the mean length
24 mm (range 15e50 mm; SD 10). The proximal aortic
neck had calcifications or thrombus extending to
25e50% of the circumference in 17 cases (35%).
An aortic neck angle between 40 and 70 was pres-
ent in 10 cases (20%) (mean 58; SD 15), while in 20
cases (41%) there was iliac tortuosity with an angle
greater than 60 (mean 85; SD 25). In 71% there
was a patent inferior mesenteric artery and in three
cases an accessory renal artery emerging from the
proximal neck. Table 2 shows the percentage oversiz-
ing (mean 16%, range 10e27%) of the main body in re-
lation to the diameter of the neck.
General anesthesia was administered in 10 cases
(20%), epidural anesthesia in 38 cases (78%) and local
anesthesia in only one case (2%). Table 3 summarizes
intra-operative data.
Table 1. Risk factors
n. patients (49) %
CIC 23 47
COBP 31 63
CRI (creat 1.5 mg/dl) 5 10
Hypertension 40 82
ACBP/PTCA 12 25
ASA II 4 8
ASA III 35 71
ASA IV 10 20
CIC: Chronic ischemic cardiopathy; COBP: Chronic obstructive
bronchopulmonary disease; CRI: Chronic renal insufficiency;
ACBP: Aorto-coronary by-pass; PTCA: Percutaneous transluminal
coronary angioplasty.Eur J Vasc Endovasc Surg Vol 34, December 2007Immediate technical success (successful implant
without conversion, death, type I or III endoleaks or
branch thrombosis) on the basis of intention-to-treat
was achieved in 100% of the 49 cases. No surgical con-
versions were performed nor were there any intra-
operative deaths. The only additional procedure carried
out in one case was the percutaneous puncture of the
brachial artery for repositioning of the ipsilateral
guidewire. During implantation, the main body was
repositioned after release in 33 cases (67%) to achieve
more satisfactory positioning.
In 3 cases (6%) it was necessary to resort to an en-
doluminal cross-over to cannulate the contralateral
gate due to the failed coupling between the inner
and outer magnets.
The main body was ballooned (Reliant, Medtronic
Inc, Minneapolis USA) in 8 cases (16%) due to the
presence of a type I proximal endoleak or to allow
greater adhesion of the prosthesis to an aortic neck
presenting significant wall thrombosis.
Iliac extensions were used in 37% of cases (18 cases:
12 unilateral, 6 bilateral) so that the prosthesis could
be released in an adequate distal neck. In 8 cases
(16%) a patent hypogastric artery was covered (in 3
cases bilaterally) due to the presence of common iliac
aneurysms. No preoperative or intraoperative hypo-
gastric artery embolisation was performed. Balloon-
ing of the docking zone was also carried out in
12 cases (24%) and of the iliac legs in 13 cases (28%).
In one case a Palmaz stent was positioned to correct
a stenosis of the iliac leg caused by calcified plaque
at the aortic bifurcation.
In all cases in which an accessory renal artery was
present, this was maintained patent by making use of
the saddle shape of the proximal stent and, if neces-
sary, by tilting the prosthesis.
Mean post-operative hospital stay was 4 days
(range 2e8 days) and only 6 patients (12%) required
Table 2. Proximal neck length and oversizing of the main body
Neck length Patients n (%) Oversize
<15% n (%) 15% n (%)
15 mm 9 (18) 3 (33) 6 (67)
15 mme20 mm 17 (35) 7 (41) 10 (59)
> 20 mm 23 (47) 10 (44) 13 (56)
Total 49 28 (57) 21 (43)
Table 3. Intra-operative data
Mean Range
Operating time (minutes) 134.2 93e225
Fluoroscopy time (minutes) 42 28e115
Contrast medium (Iomeron 400) (ml) 98.3 55e255
Units of blood transfused (300 ml) 1.4 0e4
697Preliminary Results of Anacondapost-operative intensive care (mean duration 2.5
hours; range, 0e48 hours).
Mortality, complications and secondary procedures
There was only one peri-operative death on day 21
due to an acute myocardial infarct. Peri-operative
mortality was therefore 2%.
Within the first 30 days there was one case of exter-
nal iliac artery thrombosis, two cases of iliac limb
thrombosis and one case of buttock intermittent clau-
dication due to bilateral coverage of the hypogastric
arteries.
Iliac complications are shown in Table 4. The case
of thrombosis of the external iliac artery, was caused
by an atheromatous plaque present in the common
femoral artery at the site of an arteriotomy and was
treated surgically with thrombectomy associated
with stenting. As regards the cause of iliac limb
thromboses, this was probably determined in one
case by the recoiling of a calcified plaque at the level
of the distal section of the extension (diameter
12 mm) of the external iliac artery. In the second
case there was imperfect expansion of the last distal
stent of the iliac branch and thrombosis was triggered
by significant post-operative hypotension. In both
cases we didn’t observe any kinking of the iliac limb.
Neither patient was treated, one because of death
due to MI and the other due to the presence of
mild intermittent claudication associated with a high
surgical risk.
No significant alterations were observed in serum
creatinine level in cases requiring intra-operative pro-
cedures on the neck (repositioning of the main body,
ballooning of the neck), even in cases with neck
thrombosis 50%.
Endoleaks
Intra-operative angiograms showed a proximal type I
endoleak in 4 cases, a type II in 5 cases and a type III
in 3 cases. The type I endoleaks were all treated intra-
operatively and resolved by means of ballooning.
The type III endoleaks caused by incomplete sealing
of the iliac legs at the level of the docking zone were
all treated by ballooning the docking zone (kissing
Table 4. Peri-operative complications
Complications Peri-operative %
External iliac thrombosis 1 2.0
Iliac limb thrombosis 2 4.1
Buttock claudication 1 2.0balloon). The presence of type II endoleaks in the
peri-operative period, detected by CTA and ultra-
sound with contrast medium, were observed in 25%
but there were no cases of persistent type I or type
III endoleaks.
Discussion
This prospective study highlights the main character-
istics of the Anaconda endograft, such as reposition-
ing, easy cannulation of the contralateral gate by
means of the guide system with magnets and the
extreme flexibility of the device, which distinguishes
it from other endografts available on the market.
Immediate technical success was achieved in 100%
of cases, there being no need for surgical conversion.
This compares positively with the data reported in
the literature (94%e99%).6e9 The flexibility of the An-
aconda endograft delivery system made it possible
to pass through particularly tortuous iliac access ves-
sels, thus overcoming one of the main causes of failure
to complete the procedure.10 Repositioning of the
main body, used in 67% in this series, made it possible
in fact, to correct imperfect positioning. Although
there is a theoretical risk of embolization to the renal
arteries during the collapsing and repositioning of
the device, there were no significant alterations in
serum creatinine level in the post-operative period in
our series.
The facilitated cannulation system of the contralat-
eral gate proved useful and effective in 94% of cases,
making the procedure easier even in cases of unfav-
ourable anatomy, such as accentuated angulation
between the aorta and the contralateral common iliac
artery.
Peri-operative mortality (2%) was comparable with
the experiences reported in the literature, which range
from 1% to 3%.1,2,6e8,10e14 The most frequent compli-
cation was iliac limb thrombosis, occurring in 4% of
the patients which is in the range found in the litera-
ture (1% to 7%).15,16 Neither in the cases of limb
thrombosis nor in any other case was kinking of the
iliac legs observed. This seems to be one of the most
frequent causes of iliac limb thrombosis and depends
partly on the anatomy of the iliac access and partly on
the type of endoprosthesis.16,17 In this sense, thanks to
its structure with ring-stents, Anaconda has demon-
strated excellent adaptability even in particularly tor-
tuous and angled iliac arteries.
Among the typical complications of endovascular
treatment, the presence of endoleaks is certainly the
one most widely investigated in the literature. The
percentage of endoleaks in the peri-operative periodEur J Vasc Endovasc Surg Vol 34, December 2007
698 A. Freyrie et al.varies considerably from 6% to 30%.12,18e20 In our se-
ries, the percentage of type II endoleaks was 25%, at
the top end of the range. This could be due to the
careful monitoring with CTA, echo-color-Doppler
and ultrasound with contrast medium which made
it possible to detect even endoleaks with just a slight
flow that may not be seen with other methods.
In the peri-operative period no persistent type I
endoleaks occurred, even when angled aortic necks
were present. Angulation of the proximal aortic neck
represents one of the most important reasons for fail-
ure of EVAR, making positioning and release of the
device more difficult and increasing the probability
of migrations and type I endoleaks.21,22 Stent grafts
with a very rigid main body are more exposed to com-
plications related to angled necks.22 In our series we
noted the excellent adaptability of the Anaconda en-
dograft guaranteed by the main body not supported
by stents.
Conclusions
The preliminary data obtained in the use of the second
generation Anaconda endograft for the treatment of
infrarenal AAAs with a proximal neck greater than or
equal to 15 mm in length showed complete immediate
technical success and good peri-operative results. No
surgical conversions were necessary and no persistent
type I or III endoleaks were observed. Thanks to its
structural characteristics, the Anaconda endograft
demonstrated excellent adaptability even in cases of
difficult anatomy, in particular in the presence of accen-
tuated angulation of the infrarenal neck and of the iliac
arteries. In cases with complex morphology, the facili-
tatedmagnet assisted cannulation systemof the contra-
lateral gate also proved particularly useful. The fact
that it can be repositioned also makes it particularly
suitable for staff training purposes.
Studies with larger series and a long-term follow-up
are necessary to verify the true reliability of this
endograft.
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